ACCREDITATION : API

Concord Biotech practices cGMP and its first API site (Unit-1) has been inspected by Global Regulatory Agencies like :

  • USFDA
  • EU GMP
  • Japanese AFM
  • Korean FDA
  • State GMP
  • R&D Recognition by DSIR, India
  • ANVISA (Brazil)
  • EU Regulatory authority (Bavaria, Germany)

Second API site (Unit-III), which started its operation in 2021, is designed as per cGMP and targeting Global Regulatory compliance. Unit-III has been inspected by USFDA and having regulatory approval of WHO GMP, GUJARAT STATE GMP, JAPANIESE AFM.